台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-元大-沙鹿 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-沙鹿 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/130.184.2000.0083.900.12690.02%
2024/12/1200.00192.9092.50-1233-0.43%
2024/12/0600.00197.2097.00-1220-0.45%
2024/12/0300.000.298.2097.80-0.2216-0.10%
2024/12/0200.00296.2096.10-2204-0.98%
2024/11/2900.00295.7096.20-2199-1.00%
2024/11/2500.000.197.5497.60-0.1187-0.05%
2024/11/2200.000.197.6097.50-0.1181-0.06%
2024/11/2000.00398.2397.80-3172-1.74%
2024/11/1300.00595.8896.00-5136-3.67%
2024/11/120.294.1000.0094.300.21230.16%
2024/10/010.390.8000.0091.000.31330.19%
2024/09/27189.4000.0089.8011350.74%
2024/09/200.288.4000.0088.800.21460.10%
2024/09/03188.4000.0088.5011640.61%
2024/08/30188.3000.0088.4011710.58%
2024/08/120.191.0000.0089.900.12030.05%
2024/08/0900.00191.1091.00-1204-0.49%
2024/08/0200.000.291.0091.00-0.2205-0.07%
2024/07/0200.00190.9091.20-1206-0.48%
2024/06/17090.3000.0090.8002080.00%
2024/06/050.192.8000.0092.900.12200.05%
2024/05/2000.00192.5093.40-1233-0.43%
2024/05/1700.00193.2093.90-1230-0.43%
2024/05/160.192.0000.0092.500.12250.04%
2024/05/14191.0000.0091.2012290.44%
2024/05/13291.7000.0091.8022320.86%
2024/05/10190.6000.0090.9012400.42%
2024/05/07187.9000.0088.1012420.41%
2024/04/3000.00189.0089.00-1245-0.41%
2024/04/170.188.5000.0088.400.12490.04%
2024/04/021.188.7200.0088.601.12590.42%
2024/03/29188.40188.2088.4002580.00%
2024/03/280.188.3000.0088.300.12580.02%
2024/03/26187.6000.0087.2012600.38%
2024/03/18187.1000.0086.9012840.35%
2024/03/15087.4000.0087.4002850.00%
2024/03/13287.7500.0087.9022850.70%
2024/03/110.189.800.889.8089.10-0.7275-0.26%
2024/03/08191.205.190.7490.40-4.1273-1.50%
2024/03/073.190.2400.0090.503.12691.13%
2024/03/06190.8000.0090.9012700.37%
2024/03/053.191.1900.0090.903.12741.13%
2024/02/266.191.9200.0092.106.12832.15%
2024/02/220.391.9300.0091.300.32830.11%
2024/02/210.191.2000.0091.200.12830.04%
2024/02/200.191.5000.0091.000.12840.04%
2024/02/190.191.4000.0091.500.12850.04%
2024/02/15189.4000.0089.9012930.34%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章